Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates
click to rate
Posted by Two BlokesThu at 1:00 AM -
Filed in Stock
-
1 view
Bluebird Bio (BLUE) came out with a quarterly loss of $2.66 per share versus the Zacks Consensus Estimate of a loss of $3.60. This compares to loss of $7.20 per share a year ago.